Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REVVITY, INC. | Director | Common Stock | 13.7K | $1.27M | $93.02 | Apr 30, 2025 | Direct |
Regulus Therapeutics Inc. | Director | Common Stock | 0 | $0 | $7.87 | Jun 25, 2025 | Direct |
Horizon Therapeutics Public Ltd Co | Director | Ordinary Shares | 0 | $116.50 | Oct 6, 2023 | By Trust | |
Horizon Therapeutics Public Ltd Co | Director | Ordinary Shares | 0 | $116.50 | Oct 6, 2023 | Direct | |
Horizon Therapeutics Public Ltd Co | Director | Restricted Stock Units | 0 | Oct 6, 2023 | Direct | ||
Horizon Therapeutics Public Ltd Co | Director | Stock Option (Right to Buy) | 0 | Oct 6, 2023 | Direct | ||
Regulus Therapeutics Inc. | Director | Class A-2 Convertible Preferred Stock | 0 | Jun 25, 2025 | Direct | ||
Regulus Therapeutics Inc. | Director | Stock Option | 0 | Jun 25, 2025 | Direct |